LABELLED PHOSPHOINOSITIDES AND ANALOGUES

Information

  • Research Project
  • 2793638
  • ApplicationId
    2793638
  • Core Project Number
    R43GM058992
  • Full Project Number
    1R43GM058992-01
  • Serial Number
    58992
  • FOA Number
  • Sub Project Id
  • Project Start Date
    2/1/1999 - 26 years ago
  • Project End Date
    7/31/2000 - 24 years ago
  • Program Officer Name
  • Budget Start Date
    2/1/1999 - 26 years ago
  • Budget End Date
    7/31/2000 - 24 years ago
  • Fiscal Year
    1999
  • Support Year
    1
  • Suffix
  • Award Notice Date
    1/25/1999 - 26 years ago
Organizations

LABELLED PHOSPHOINOSITIDES AND ANALOGUES

DESCRIPTION (Adapted from the application): The overall objective of this study is to develop syntheses of labeled cellular phosphoinositides tagged with stable or radioactive isotopes. A strategy for synthesis is suggested which also provides a concise synthesis of the natural phosphoinositides. During Phase I, the feasibility of labeling in the inositol moiety with hydrogen isotopes will be established by the synthesis of a representative polyphosphorylated phosphoinositide. In Phase II, the synthesis will be adapted and extended to the complete series of cellular phosphoinositides and analogues tagged with selected isotope labels. The phosphoinositides are vital components of the pool of intracellular mediators in signaling, and undergo active metabolic changes in response to external stimuli and during cell cycle. The target products of this proposal are needed (I) as research reagents for studying interactions with enzymes and regulatory proteins of intracellular signaling cascades, (ii) as tracers and reference compounds for metabolic pathways of the phosphoinositides in the development of new drug modalities for aberrant intracellular signaling, and (iii) for developing medical diagnostics. PROPOSED COMMERCIAL APPLICATION: Labelled phosphoinositides and their metabolites are useful as research biochemicals and diagnostic reagents. The synthetic methodology has utility for developing analogues and congeners as potential drugs and biotechnology aids.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R43
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG3
  • Study Section Name
  • Organization Name
    NUTRIMED BIOTECH
  • Organization Department
  • Organization DUNS
  • Organization City
    ITHACA
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    14850
  • Organization District
    UNITED STATES